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(7) Observational findings will need to be followed up with in vitro or in vivo experiments, leading to the molecular mechanisms responsible for the observed interactions.
(8) Complex phenotype and genotype interactions require the analysis of their combined effects. The current statistical tools are limited in their ability to deal with this complexity. Therefore development of appropriate statistical tools will become indispensable for analysing and understanding the effects of variations in multiple genes, in combination with a large body of environmental and phenotypic information. Likewise, the information will need to be incorporated into predictive models that can then be used clinically to improve disease assessment and prevention.
(9) Finally, bioinformatics will allow a more comprehensive integration of the knowledge generated by different areas of research.
Summary
Nutrigenomics is evolving as a most promising area of research that will revolutionize nutrition research and public health. The increased ability to generate genotypic information, in combination with knowledge from the Human Genome Project and more comprehensive experimental designs, will dramatically improve our capacity to answer many of our current questions and to prove the validity of the goal behind this research ; namely, to demonstrate that knowledge of an individual's genetic background will facilitate more precise dietary counselling and intervention and more efficacious primary and secondary CHD prevention. The knowledge and models developed for cardiovascular disease will also be applicable to the other major diseases that plague modern society.
Introduction
The revolutionary miniaturization of analytical instrumentation and methodologies is nowhere more evident than in microfluidic systems. By accomplishing common laboratory procedures from filtration and mixing to separation and detection in planar 'chip ' format, this technology can revolutionize a host of existing and emerging bioanalytical applications. Rapid progress in microfluidics relies upon advances in microfabrication technologies, customized assay chemistries, materials development and packaging concepts, marrying everything from biology to electrical engineering in a single monolithic microsystem.
Based upon interconnected networks of microchannels and reservoirs with tiny volumes, microfluidic devices are well matched to the demands for small volume, rapid response, parallel analyses and minimal cross-contamination that characterize applications in biotechnology. Accordingly, many promising applications of microfluidic systems are found in genetic analysis, pharmaceutical discovery and medical diagnosis. This review focuses on plastic microfluidic systems, which have sufficiently low manufacturing costs to be both disposable and adaptable -in the form of highly customized designs for each application -to a wide range of problems.
Progress towards microfabricated liquidphase analytical systems made a revolutionary leap when electrokinetic phenomena were proposed as a means to motivate and separate dissolved species on planar chips. Electrophoresis provides high-resolution, low-dispersion separations, while electro-osmosis can pump dissolved charged and neutral species, as well as solvent, through capillaries and microchannels using electric fields. When filled with ion-containing aqueous solution, channels made from glass and similar materials have a pH-dependent fixed charge bound to their wetted surfaces. At neutral to basic pH values, this charge is negative. Some moderately polar polymers, such as poly(methylmethacry1ate) and poly(carbonate), also have measurable fixed negative surface charges at appropriate p H values. Immobile surface charge attracts a layer of partially solvated charge-compensating (positive) ions from solution; application of a high electric field along the length of the channel causes the layer of counter-ions to move along the walls. For sufficiently small channel diameters (typically 10-lOOpm), movement of a sheath of solvent at the walls entrains the liquid in the entire capillary. The resulting liquid motion is often described as 'plug' flow : the velocity is essentially uniform at all points across the diameter of the channel.
Consequently, a bolus of material that starts at one end of the column is not distorted in shape as it moves down the channel under electro-osmotic motivation.
T h e capability to motivate and separate exceptionally small liquid volumes with precise electrical control is a powerful tool, which is complemented by an additional scaling-related consequence of using microchannels : two or more channels can intersect to form a tee, cross, or other such structure. By controlling the potential on each channel separately, fluid streams can be metered quantitatively to create mixtures of desired composition. In essence, this electronically controlled metering mimics valve functionality. T h e combination of electrokinetic pumping, valving and separation within interconnected networks of microchannels on planar substrates was described in the early to mid-1 990s by These workers demonstrated implementations of separations of solution species using microfabricated chip devices, and several groups explored ' integrated ' chip capillary electrophoresis (CE), wherein various analytical protocols (mixing, reaction and separation) were included on a monolithic chip [13-151.
Materials and methods

Plastic substrate materials
Soane and Soane [l] and Ekstrom et al. [16]
proposed the use of polymeric materials in chip CE. While the microfabrication of inorganic materials such as silicon or glass can be accomplished inexpensively when chip sizes are small ( -1 cm'), larger fluidic devices ( -100 cm') are often a better match for applications such as the separation of DNA fragments or the screening of large numbers of pharmaceutical candidates. In addition, the reservoir drilling and sealing of inorganic substrates (by high-temperature fusion bonding of a glass cover layer, for example) are relatively expensive processes. In contrast, plastic parts made by techniques such as injection moulding, casting or embossing can be quite inexpensive (the manufacturing cost of an injection-moulded compact disc is presently less than U.S. $0.30).
Thus plastic fluidic devices can be made so cheaply as to be disposable after a single use.
T h e chemical, optical, electrical and mechanical properties of both the base card material and the sealing layer must be compatible with the chemical reagents and procedures, the electric field-driven motivation of solvent and solute through the microchannels, and the method selected to detect the analytical targets. Fortunately, a number of organic polymer materials have demonstrated compatibility with these requirements, including various polysiloxanes, polyacrylates ('acrylics '), polyolefins and polycarbonates.
Microfluidic device fabrication
Among the methods for forming capillary-size channels in polymeric substrates, 'direct ' techniques, such as mechanical machining or laser ablation, are not the most economical, and in some cases produce surfaces that are too rough for highresolution electrophoresis. Replication methods, including injection moulding, compression moulding, embossing and casting, shift the burden of forming a high-quality surface to the creation of the template, master or mould tool from which the polymer part is to be formed. Such techniques are demonstrably economical when large numbers of identical plastic parts or devices are formed using extant manufacturing methods and machinery.
One approach, similar to that used in the commercial manufacture of compact discs, involves two primary steps : (1) formation of ' open ' microstructures, such as channels and reservoirs, on one surface of a base layer of polymer, and (2) sealing of the features in the base layer by a plastic cover layer [17, 18] . T o form the base layer, fluidic features are first microfabricated on a glass or silicon wafer or plate using standard photolithographic patterning and etching techniques. Next, a metal mould tool is created by electroplating a few tenths to several millimetres of metal, creating a precise replicate ' electroform ' with inverse topology. This tool can be used on an embossing machine or an injection or compression moulding system. Polymer substrates are then manufactured in volume from melted or softened polymer resin or sheet to create extremely smooth and precise channels in the finished fluidic device or card. The open microchannels and reservoirs of a moulded or embossed fluidic device are sealed to form closed capillaries by bonding to the surface a smooth plaque or thin film of polymer material ; sealing is accomplished using an adhesive interlayer or by chemical or thermal techniques that fuse the two layers.
The microchannels are typically tens of micrometres in diameter and follow complex circuit-like paths that can be centimetres in length.
Reagents are fed to these channels via reservoirs, typically 1-2 mm in diameter and penetrating the depth of the card ( -1 mm), resulting in total reagent volumes of 1-1Oyl per reservoir. Hundreds of reservoirs and metres of channels can be densely packed into multiplexed designs that form 96 or even 384 assay patterns on a single 8 cm x 12 cm disposable card.
Detection
Miniaturization of analytical instrumentation requires the detection of ever-decreasing sample amounts. Although techniques such as laserinduced fluorescence (LIF) are sensitive to decreases in the interrogated volume, they maintain impressive detection limits when coupled with microfabricated devices : single-molecule detection has been reported [19] . More routinely, L I F using confocal detection can detect molecules, labelled with appropriate fluorophores, at concentrations of approx. 10 p M ; with nanolitre detection volumes, the number of molecules detected is hundreds to thousands. Confocal epifluorescence detection with a pinhole positioned in the image plane, coupled with high-numericalaperture objectives, enhances the signal/noise ratio by rejecting background radiation and collecting light efficiently. An alternative strategy is to use near-IR-absorbing fluorophores, since background fluorescence is typically less in this wavelength region. Interestingly, under conditions of photobleaching of the polymer chip, the background fluorescence from appropriately selected plastic materials when excited by laser light at 488 nm is comparable with the background from a glass microfluidic device of similar thickness.
Results and discussion
Screening of pharmaceutical candidates
The search for new pharmaceutical candidates is a multibillion-dollar effort, with an annual growth rate approaching 20 yo. While molecular design has made giant strides, the interactions of complex biological molecules are not understood sufficiently for side-effect-free drugs to be designed on the first pass. More typically, hundreds of thousands of test compounds from the libraries of pharmaceutical companies are screened against targets such as enzymes, receptors and cells. Following this primary screen, a small subset of promising 'hits ' is studied further with secondary screens and clinical trials to identify undesirable side effects and prove efficacy before a satisfactory choice can be made. Combinatorial chemistry has increased exponentially the number of test compounds available, while advances in genomics have broadened the variety of targets, giving rise to the need to perform an exponentially increasing number of screening assays. However, even 1 pl of expensive or hard-to-obtain target or test compound can dominate the cost of an assay. Therefore it is critical to limit reagent volumes so that libraries of pharmaceutical compounds can be screened against many more targets.
A common method for screening test compounds involves mixing microlitre volumes of enzyme, fluorogenic substrate and a candidate inhibitor and, after a fixed incubation period, quantifying the amount of product formed via fluorescence detection. For more challenging assays in which signals from multiple fluorescent species are not easily decoupled, or when library compounds are so scarce and expensive that multiplexing is warranted, separation techniques can be employed. Assay precision and reproducibility are enhanced further by spiking the mixture with known concentrations of internal standards with well characterized separation times. We have developed a microfluidic format that offers the advantage of integrated incubation and electrophoretic separation on a single plastic card. Assays of activity for kinase-, phosphatase-and protease-catalysed reactions have been demonstrated ; separations are performed over a wide range of pH and assay conditions. Separations are rapid, occurring in seconds, because the action of the enzyme typically alters significantly the charge/mass ratio of the product relative to that of the substrate. An electropherogram obtained using a plastic fluidic system to assay the substrate and product of a kinase-catalysed reaction is shown in Figure 2 . 
DNA sequencing
Sequencing the human genome has been accomplished at a remarkable pace, due in large part to the utilization of capillary-array electrophoresis (CAE) instruments, which provide increased efficiency and reduced costs compared with slabgel electrophoresis systems. Capillary bundles filled with high-molecular-mass sieving polymers, Figure I Nanovolume homogeneous assay card, comprising 96 sets of microchannel-coupled assay and evaporation-
control reservoirs
The fluidic architecture enables 'pinning' of the meniscus near the bottom of the assay reservoir. After filling the evaporation-control reservoir with -5 pl of dilute buffer solution, a few hundred nanolitres of assay reagents can be dispensed directly into the assay well and maintained at near-constant volume for over I h. Electropherogram obtained using a plastic fluidic system to assay the substrate and product of a kinasecatalysed reaction C,-C, are spiked control substances. a.u., arbitrary units. 
Evaporation
77
Multiplexed assay of gene and protein expression Quantitative information provided by changes in the relative patterns of expression of genes and, ultimately, the relative quantification of the proteins that they encode, can speed progress in understanding a range of critical biochemical interactions, including those that must be deciphered in order to develop new, more effective pharmaceuticals. We have developed unique chemistry (the 'eTagTM ' assay system) that allows simultaneous multiplexed quantification of tens of genes and/or proteins in a single, homogeneous solution-phase assay. Molecular binding events, including the hybridization of a nucleic acid target sequence with a matching probe sequence or the specific interaction between a protein target and an antibody, lead to the release of fluorescently labelled ' eTag reporters ' in direct proportion to the concentration of each target species. These reporters are then separated according to their unique and well characterized electrophoretic reaction has been demonstrated by concurrent assay of the interleukin-6 mRNA and protein from Thp-1 cells, as a function of time, in a single experiment. T h e results showed a peak in the expression of the interleukin-6 gene after an induction period of approx. 2 h, and much later, after some 18 h of induction, a peak in the expression of interleukin-6 protein. Current limits of detection for this technology are in the low picomolar range, with further improvements anticipated.
Conclusions
T h e assay results presented in this paper represent a few examples of the integrated analytical processes that can be performed in microfluidic devices, with emphasis on the power of electrophoretic separations to increase accuracy, speed throughput and facilitate highly parallel analyses. Other chemical processes, such as reaction and purification steps, are being integrated with separations on microfluidic devices to realize the ' labon-a-chip ', ' sample-to-answer ' goal, a vision with the potential to revolutionize the process of biochemical analysis.
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